BAHA Skin Complications in the Pediatric Population: Systematic Review With Meta-analysis

Shapiro, Scott; Ramadan, Jad; Cassis, Adam

doi:10.1097/mao.0000000000001877

Cited by 30 publications

(13 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Few of these previous studies, however, have evaluated long-term outcomes in patients with bilateral microtia-atresia (7,20). After 2 years of follow-up, the complication rates were similar to those reported previously for these devices (21,22).…”

Section: Discussionsupporting

confidence: 87%

Long-term Outcomes of Bone Conduction Hearing Implants in Patients With Bilateral Microtia-atresia

Fan

Yang

Niu

et al. 2019

Otology &Amp; Neurotology

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 87%

Long-term Outcomes of Bone Conduction Hearing Implants in Patients With Bilateral Microtia-atresia

Fan

Yang

Niu

et al. 2019

Otology &Amp; Neurotology

View full text Add to dashboard Cite

show abstract

“…La clasificación de Holgers evalúa la gravedad de la reacción de los tejidos blandos a los pilares, con grado 0 para ninguna Los implantes auditivos de conducción ósea transcutáneos, como el BAHA Attract®, utilizan la retención magnética para anclar el procesador de sonido al implante osteointegrado, dejando la piel intacta sobre el implante (13); este sistema de anclaje podría ayudar a superar en buena medida las complicaciones en la piel. Una revisión sistemática con un metaanálisis encontró diferencias significativas en la tasa estimada de complicaciones en la piel entre los implantes transcutáneos (6,3 %) frente a los implantes percutáneos (30 %), al igual que en los porcentajes de pérdida del implante, que fue del 0 % para los implantes transcutáneos frente al 5,3 % para los implantes percutáneos (6). Bajo esta perspectiva, una opción razonable en los pacientes con implantes osteointegrados percutáneos que presentan complicaciones significativas y de manera repetida en la piel es hacer el cambio por un implante transcutáneo (14,15).…”

Section: Reacciones En Pielunclassified

Resultados audiológicos y de calidad de vida en pacientes con transición del sistema Baha Connect® a Baha Attract®

Ordóñez¹,

Ge²,

Sc³

et al. 2020

Acta otorrinolaringol cir cabeza cuello

View full text Add to dashboard Cite

Introducción: los implantes auditivos de conducción ósea percutáneos han sido usados de forma exitosa. Sin embargo, un número importante de pacientes reportan reacciones en piel repetitivas. Los implantes auditivos transcutáneos son una alternativa que pueden solventar estas complicaciones. Con este estudio queremos describir los resultados audiológicos y de calidad de vida en pacientes que requirieron transición del sistema percutáneo a transcutáneo.Metodología: estudio observacional descriptivo, se incluyeron pacientes con implante auditivo percutáneo que requirieron transición a sistema transcutáneo. Se evaluó el desempeño auditivo utilizando una prueba con fondo ruidoso y se aplicó la escala de calidad de vida “Glasgow Benefit Inventory”-GBI.

show abstract

“…Minor complications were symptomatic skin reactions requiring intravenous antibiotics, cautery or grafting in 8%, while the other 8% of patients suffered from thickening or overgrowth of skin requiring excision, and 1% had graft necrosis [Badran et al, 2009]. Shapiro et al [2018] published a meta-analysis comparing transcutaneous versus percutaneous BCIs (tBCIs vs. pBCIs). The study showed an overall skin complication rate for tBCIs of 6.3% versus 30% for pBCIs, while the implant loss was 0% for tBCIs and 5.3% for pBCIs, and finally the reoperation rate was 3 and 6.2% for tBCIs and pBCIs, respectively.…”

Section: Introductionmentioning

confidence: 99%

One-Year Follow-Up in Children with Conductive Hearing Loss Using ADHEAR

Zernotti¹,

Alvarado²,

Zernotti³

et al. 2021

Audiol Neurotol

View full text Add to dashboard Cite

Background: The ADHEAR™ system (MED-EL, Innsbruck, Austria) is a nonsurgical bone conduction device (BCD) to treat conductive hearing loss (CHL) and single-sided deafness. In contrast to the nonsurgical alternatives on headbands or spectacle frames, the audio processor of ADHEAR is placed retroauricularly on an adhesive adapter. The published evidence on the performance of this system is limited to studies with a trial period of 2–8 weeks. Objective: This study assesses audiological and subjective outcomes over a period of 12 months, on patients with congenital aural atresia (CAA) using the ADHEAR hearing system. Method: Fifteen children (mean age: 9.4 ± 4 years; range: 5–16 years) diagnosed with CAA (7 uni/8 bilateral) were included in this prospective, observational, repeated-measures study. Each subject used ADHEAR for 1 year, and the performance was evaluated after 1, 6, and 12 months. Free-field audiometry and speech discrimination tests were performed, and hearing-, general health- and device-specific questionnaires were used. Results: The unaided sound field threshold improved from an average PTA4 of 63.6 ± 3.4 dB HL to an aided average PTA4 of 29.3 ± 3.0 dB HL after 1 month of device use. The word recognition score (WRS) improved from an average of 27.9 ± 15.9% unaided to an aided average WRS of 91.3 ± 4.4% (p = 0.0003) after 1 month, 92.0 ± 4.1% (p = 0.0002) after 6 months, and 92.7 ± 5.3% (p < 0.0001) after 12 months using the ADHEAR system compared to the unaided condition for all 3 time points. The improvements in the speech in noise at 1, 6, and 12 months were as well consistent over time. The average improvement at the signal to noise ratio (SNR) of +5 dB was 58% and 53% at the SNR of +0 dB. No complications were reported, and all patients continued to use the ADHEAR after the study end. The questionnaire results revealed high user satisfaction and an average wearing time of 12 h per day. Conclusion: This 12-month trial of the nonsurgical adhesive BCD in CAA patients showed sufficient and reliable audiological and subjective outcomes, long wearing time, and high acceptance. The ADHEAR can be considered a suitable option to treat children with CAA for the given indication, without the drawbacks of nonsurgical devices that use pressure for retention of the audio processor or the costs and possible complications involved with a surgical alternative.

show abstract

BAHA Skin Complications in the Pediatric Population: Systematic Review With Meta-analysis

Abstract: There is strong evidence to suggest that in pediatric patients, the incidence of skin complications, implant loss, and rate of reoperation are higher for pBCIs compared with tBCIs. This information should be part of any discussion about BCI surgery on a pediatric patient.

Cited by 30 publications

References 45 publications

Long-term Outcomes of Bone Conduction Hearing Implants in Patients With Bilateral Microtia-atresia

Long-term Outcomes of Bone Conduction Hearing Implants in Patients With Bilateral Microtia-atresia

Resultados audiológicos y de calidad de vida en pacientes con transición del sistema Baha Connect® a Baha Attract®

One-Year Follow-Up in Children with Conductive Hearing Loss Using ADHEAR

Contact Info

Product

Resources

About